20 September 2018
Pirbright switches it up: creating foot-and-mouth disease hybrids for better vaccines
In collaborative research led by The Pirbright Institute, scientists have generated a ‘hybrid’ foot-and-mouth disease virus (FMDV) with improved stability, which will increase its effectiveness when administered as a vaccine. They targeted the Southern African Territories (SAT) 2 serotype viruses…
Read more
